๐ Ainos: AI Nose and VELDONA, Innovations Transforming Healthcare
lang:en
Ainos Pushes the Boundaries of Smart Healthcare with AI Nose and VELDONA
Ainos, Inc. (NASDAQ: AIMD) continues to innovate in digital healthcare with two revolutionary technologies: the AI Nose (AI-powered digital nose) and VELDONA (low-dose oral interferon). Here's an overview of their applications and latest progress.
๐ AI Nose: The Digital Nose That "Sniffs" Disease
- ๐ฌ VOC Detection — AI Nose simulates human olfaction by detecting volatile organic compounds, with 22 gases detected at 79% accuracy.
- ๐ฅ Early Diagnosis — Exhaled breath analysis to identify respiratory abnormalities, reducing the need for invasive procedures.
- ๐ฉ Ainos Flora — Second-generation optimized for home use, detecting vaginal infections and STIs in women, with clinical trials expected by end of 2024.
- ๐ญ Industrial Safety — Real-time monitoring of harmful chemicals to protect workers.
- ๐ค Humanoid Robots — Enables robots to detect gas leaks, hazardous substances, or abnormal odors, improving autonomy and safety.
- ๐ Elderly Care — Solution for long-term care facilities, with trial production expected by end of 2024.
๐ VELDONA: Low-Dose Oral Interferon
- ๐ฆ Viral Diseases — Treatment for COVID-19 and influenza, modulating the immune system with fewer side effects.
- ๐ก️ Sjรถgren's Syndrome — Promising clinical trial results with significant quality-of-life improvements.
- ๐พ Veterinary — Trials underway for feline chronic gingivostomatitis, with potential in the global pet healthcare market.
- ๐ FDA Orphan Drug — FDA designation for HIV-related oral warts, with market exclusivity and tax incentives.
๐ค Key Collaborations
- ๐จ๐ญ Partnership with Swiss pharmaceutical company for global VELDONA commercialization
- ๐ฌ Partnership with Topmed Biotech for pet health supplements
- ๐ Joint VOC platform development with Nisshinbo and Inabata Sangyo
- ๐งช Agreement with Carbon Nano Technology for VOC and POCT
๐ Learn more about Ainos: https://www.ainos.com
Follow Ainos on @AinosInc and LinkedIn to stay updated.
Source: ainos.com/news_view/62